Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer

NCT07683403 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer (CRC)

Interventions

DRUG: Savolitinib plus cetuximab and FOLFOX chemotherapy
DRUG: Cetuximab and FOLFOX chemotherapy

Sponsor

Fudan University